You can find more information about PF3D7_1347200-Nt1 using the following links:

Subcellular Localization

• Picture 1
• Picture 2
• Picture 3
• Picture 4
• Picture 5
• Picture 6
• Picture 7
• Picture 8
• Picture 9

Affecting Drugs
Drug Name	PubMed Articles (year of publication)
(2R,3S,4R,5R)-2-(hydroxymethyl)-5-[6-[2-[2-[2-(1-naphthyloxy)ethoxy]ethoxy]ethylamino]purin-9-yl]tetrahydrofuran-3,4-diol	Anti-malarial activity of N(6)-substituted adenosine derivatives. Part I(2002)
2-[2-(2-methyphenyl)vinyl]-4(3H)-quinazoline	Yeast-based high-throughput screen identifies Plasmodium falciparum equilibrative nucleoside transporter 1 inhibitors that kill malaria parasites(2015)
2-Hydroxy-7-methoxy-2-(1,1,2,2,2-pentafluoroethyl)-3H-chromen-4-one	Structural basis of transport and inhibition of the Plasmodium falciparum transporter PfFNT(2021)
3-[2-[2-[2-[[9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]purin-6-yl]amino]ethoxy]ethoxy]ethylamino]-1,1-diphenyl-propan-2-one	Anti-malarial activity of N(6)-substituted adenosine derivatives. Part I(2002)
4-(3a,7a-dihydro-1H-indol-3-yl)-N-[2-[[9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]purin-6-yl]amino]ethyl]butanamide	Anti-malarial activity of N(6)-substituted adenosine derivatives. Part I(2002)
4-[benzyl(ethyl)amino]-N-[2-[[9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]purin-6-yl]amino]ethyl]-3-nitro-benzamide	Anti-malarial activity of N(6)-substituted adenosine derivatives. Part I(2002)
4-methyl-7-[(3,4,5-trimethoxybenzyl)oxy]-2H-chromen-2-one	Yeast-based high-throughput screen identifies Plasmodium falciparum equilibrative nucleoside transporter 1 inhibitors that kill malaria parasites(2015)
5-methyl-N-[2-(2-oxo-1-azepanyl)ethyl]−2-phenyl-1,3-oxazole-4-carbox-amide	Structural basis of the substrate recognition and inhibition mechanism of Plasmodium falciparum nucleoside transporter PfENT1(2023)
Difference from host, suggested target	Identification of a nucleoside/nucleobase transporter from Plasmodium falciparum, a novel target for anti-malarial chemotherapy(2000)
Kinetic characterization, suggested target	Transport of purines and purine salvage pathway inhibitors by the Plasmodium falciparum equilibrative nucleoside transporter PfENT1(2010)
N(6)-substituted adenosine derivatives	Anti-malarial activity of N(6)-substituted adenosine derivatives. Part I(2002)
N,N'-(benzo[d]thiazole-2,6-diyl)bis(furan-2-carboxamide)	Impact of Field Isolate Identified Nonsynonymous Single Nucleotide Polymorphisms on Plasmodium falciparum Equilibrative Nucleoside Transporter 1 Inhibitor Efficacy(2020)
N,N'-1,3-benzothiazole-2,6-diyldi(2-furamide)	Yeast-based high-throughput screen identifies Plasmodium falciparum equilibrative nucleoside transporter 1 inhibitors that kill malaria parasites(2015)
N-[2-[2-[2-[[9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]purin-6-yl]amino]ethoxy]ethoxy]ethyl]-4-oxo-4-(4-phenylphenyl)butanamide	Anti-malarial activity of N(6)-substituted adenosine derivatives. Part I(2002)
N6-hydroxy-9H-purin-6-amine	A comprehensive model of purine uptake by the malaria parasite Plasmodium falciparum: identification of four purine transport activities in intraerythrocytic parasites(2008)
N-Cyclopropyl-2-{[3-(2-oxo-1-pyrrolidinyl)benzoyl]amino}benzamide	Identification via a Parallel Hit Progression Strategy of Improved Small Molecule Inhibitors of the Malaria Purine Uptake Transporter that Inhibit Plasmodium falciparum Parasite Proliferation(2019)
Plasmodium specific phosphatases, suggested target	Purine import into malaria parasites as a target for antimalarial drug development(2015)